1
|
Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.
|
Circulation
|
2003
|
23.97
|
2
|
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.
|
N Engl J Med
|
2002
|
16.23
|
3
|
Multiple biomarkers for the prediction of first major cardiovascular events and death.
|
N Engl J Med
|
2006
|
15.60
|
4
|
Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score.
|
JAMA
|
2007
|
15.32
|
5
|
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women.
|
JAMA
|
2007
|
9.68
|
6
|
C-reactive protein levels and outcomes after statin therapy.
|
N Engl J Med
|
2005
|
9.47
|
7
|
Plasma adiponectin levels and risk of myocardial infarction in men.
|
JAMA
|
2004
|
7.46
|
8
|
C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men.
|
Circulation
|
2008
|
7.33
|
9
|
C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women.
|
Circulation
|
2003
|
6.99
|
10
|
Sex hormone-binding globulin and risk of type 2 diabetes in women and men.
|
N Engl J Med
|
2009
|
6.16
|
11
|
Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk.
|
J Am Coll Cardiol
|
2004
|
6.08
|
12
|
Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women.
|
Am J Med
|
2007
|
5.95
|
13
|
Inflammatory markers and the risk of coronary heart disease in men and women.
|
N Engl J Med
|
2004
|
5.86
|
14
|
C-reactive protein and the risk of developing hypertension.
|
JAMA
|
2003
|
5.75
|
15
|
Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women.
|
JAMA
|
2005
|
5.74
|
16
|
C-reactive protein and the risk of incident colorectal cancer.
|
JAMA
|
2004
|
4.94
|
17
|
Serum aldosterone and the incidence of hypertension in nonhypertensive persons.
|
N Engl J Med
|
2004
|
4.92
|
18
|
Inflammatory markers and risk of developing type 2 diabetes in women.
|
Diabetes
|
2004
|
4.67
|
19
|
Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey.
|
Circulation
|
2004
|
4.58
|
20
|
Association between C-reactive protein and age-related macular degeneration.
|
JAMA
|
2004
|
4.16
|
21
|
Body iron stores in relation to risk of type 2 diabetes in apparently healthy women.
|
JAMA
|
2004
|
4.04
|
22
|
Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women.
|
Circulation
|
2009
|
3.93
|
23
|
Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.
|
Circulation
|
2005
|
3.85
|
24
|
Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus.
|
JAMA
|
2004
|
3.69
|
25
|
Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction.
|
Am J Clin Nutr
|
2004
|
3.61
|
26
|
Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction.
|
Am J Clin Nutr
|
2005
|
3.55
|
27
|
The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia.
|
N Engl J Med
|
2004
|
3.50
|
28
|
Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events.
|
Circulation
|
2008
|
3.03
|
29
|
Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.
|
JAMA
|
2002
|
3.01
|
30
|
Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide.
|
Circulation
|
2002
|
2.86
|
31
|
Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women.
|
PLoS Genet
|
2008
|
2.85
|
32
|
Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and the development of symptomatic peripheral arterial disease in men.
|
Circulation
|
2002
|
2.84
|
33
|
Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women.
|
Arterioscler Thromb Vasc Biol
|
2002
|
2.79
|
34
|
Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death.
|
Circulation
|
2002
|
2.78
|
35
|
Effects of a low-glycemic load diet on resting energy expenditure and heart disease risk factors during weight loss.
|
JAMA
|
2004
|
2.70
|
36
|
Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women.
|
Circulation
|
2003
|
2.52
|
37
|
Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach.
|
Mol Cell Proteomics
|
2014
|
2.37
|
38
|
Serum estrogen, but not testosterone, levels differ between black and white men in a nationally representative sample of Americans.
|
J Clin Endocrinol Metab
|
2007
|
2.36
|
39
|
Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women.
|
Circulation
|
2002
|
2.36
|
40
|
Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: the Women's Health Initiative Observational Study.
|
Diabetes Care
|
2007
|
2.33
|
41
|
Comparison of LDL cholesterol concentrations by Friedewald calculation and direct measurement in relation to cardiovascular events in 27,331 women.
|
Clin Chem
|
2009
|
2.31
|
42
|
High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study.
|
Circulation
|
2003
|
2.28
|
43
|
Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women.
|
JAMA
|
2006
|
2.27
|
44
|
Association of leukocyte telomere length with circulating biomarkers of the renin-angiotensin-aldosterone system: the Framingham Heart Study.
|
Circulation
|
2008
|
2.22
|
45
|
Circulating levels of endothelial adhesion molecules and risk of diabetes in an ethnically diverse cohort of women.
|
Diabetes
|
2007
|
2.19
|
46
|
Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction.
|
J Nutr
|
2005
|
2.17
|
47
|
A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
2.15
|
48
|
Low-grade albuminuria and the risks of hypertension and blood pressure progression.
|
Circulation
|
2005
|
2.09
|
49
|
Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers.
|
Arch Ophthalmol
|
2005
|
2.08
|
50
|
Androgens and diabetes in men: results from the Third National Health and Nutrition Examination Survey (NHANES III).
|
Diabetes Care
|
2007
|
2.08
|
51
|
Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation.
|
Clin Chem
|
2002
|
2.06
|
52
|
A prospective study of inflammatory cytokines and diabetes mellitus in a multiethnic cohort of postmenopausal women.
|
Arch Intern Med
|
2007
|
2.05
|
53
|
Homocysteine, 5,10-methylenetetrahydrofolate reductase 677C>T polymorphism, nutrient intake, and incident cardiovascular disease in 24,968 initially healthy women.
|
Clin Chem
|
2007
|
2.05
|
54
|
Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial.
|
Circulation
|
2005
|
2.02
|
55
|
Lipoprotein(a) and risk of type 2 diabetes.
|
Clin Chem
|
2010
|
2.01
|
56
|
Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: a cohort study.
|
Ann Intern Med
|
2008
|
2.01
|
57
|
Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudy.
|
Circulation
|
2004
|
1.99
|
58
|
Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction.
|
Circulation
|
2008
|
1.95
|
59
|
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the laboratory science discussion group.
|
Circulation
|
2004
|
1.93
|
60
|
Dietary intake of trans fatty acids and systemic inflammation in women.
|
Am J Clin Nutr
|
2004
|
1.88
|
61
|
Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18.
|
Eur Heart J
|
2008
|
1.88
|
62
|
Adiponectin and future coronary heart disease events among men with type 2 diabetes.
|
Diabetes
|
2005
|
1.87
|
63
|
Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.80
|
64
|
C-reactive protein and cardiovascular disease: a review of risk prediction and interventions.
|
Clin Chim Acta
|
2002
|
1.78
|
65
|
Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines.
|
Circulation
|
2004
|
1.78
|
66
|
Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
|
Circulation
|
2007
|
1.76
|
67
|
Association of markers of insulin and glucose control with subsequent colorectal cancer risk.
|
Cancer Epidemiol Biomarkers Prev
|
2003
|
1.75
|
68
|
B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.
|
J Am Coll Cardiol
|
2004
|
1.75
|
69
|
A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts.
|
J Natl Cancer Inst
|
2012
|
1.74
|
70
|
Relation between markers of systemic vascular inflammation and smoking in women.
|
Am J Cardiol
|
2002
|
1.73
|
71
|
Interactions between the -514C->T polymorphism of the hepatic lipase gene and lifestyle factors in relation to HDL concentrations among US diabetic men.
|
Am J Clin Nutr
|
2005
|
1.72
|
72
|
Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women.
|
J Nutr
|
2004
|
1.70
|
73
|
High-sensitivity C-reactive protein: clinical importance.
|
Curr Probl Cardiol
|
2004
|
1.69
|
74
|
Lipoprotein(a), hormone replacement therapy, and risk of future cardiovascular events.
|
J Am Coll Cardiol
|
2008
|
1.69
|
75
|
Plasma fluorescent oxidation products as potential markers of oxidative stress for epidemiologic studies.
|
Am J Epidemiol
|
2007
|
1.68
|
76
|
National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease.
|
Clin Chem
|
2008
|
1.65
|
77
|
Insulin, proinsulin, proinsulin:insulin ratio, and the risk of developing type 2 diabetes mellitus in women.
|
Am J Med
|
2003
|
1.62
|
78
|
Stability of novel plasma markers associated with cardiovascular disease: processing within 36 hours of specimen collection.
|
Clin Chem
|
2002
|
1.59
|
79
|
Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?
|
J Am Coll Cardiol
|
2006
|
1.59
|
80
|
Dietary glycemic index, glycemic load, cereal fiber, and plasma adiponectin concentration in diabetic men.
|
Diabetes Care
|
2005
|
1.57
|
81
|
Concentrations of C-reactive protein and B-type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascular death.
|
Clin Chem
|
2008
|
1.56
|
82
|
Blood pressure, C-reactive protein, and risk of future cardiovascular events.
|
Circulation
|
2003
|
1.56
|
83
|
Identifying duplicate publications: primum non nocere.
|
Clin Chem
|
2008
|
1.55
|
84
|
Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes.
|
Diabetes Care
|
2004
|
1.53
|
85
|
An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports.
|
Clin Chim Acta
|
2012
|
1.51
|
86
|
An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports.
|
Transfusion
|
2012
|
1.50
|
87
|
Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial.
|
Circulation
|
2003
|
1.49
|
88
|
Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial.
|
Circulation
|
2006
|
1.48
|
89
|
Sensitive cardiac troponin T assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: the Women's Health Study.
|
Circulation
|
2011
|
1.47
|
90
|
E-selectin genotypes and risk of type 2 diabetes in women.
|
Obes Res
|
2005
|
1.46
|
91
|
Commercial immunoassays in biomarkers studies: researchers beware!
|
Clin Chem Lab Med
|
2013
|
1.44
|
92
|
Association of cigarette smoking, alcohol consumption, and physical activity with sex steroid hormone levels in US men.
|
Cancer Causes Control
|
2009
|
1.43
|
93
|
C-reactive protein concentration distribution among US children and young adults: findings from the National Health and Nutrition Examination Survey, 1999-2000.
|
Clin Chem
|
2003
|
1.42
|
94
|
A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival.
|
Clin Chem
|
2009
|
1.41
|
95
|
The +276 polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic men.
|
Diabetes
|
2005
|
1.38
|
96
|
Plasma 25-hydroxyvitamin D and risk of pancreatic cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
1.37
|
97
|
A girl with goiter and inappropriate thyroid-stimulating hormone secretion.
|
Clin Chem
|
2008
|
1.36
|
98
|
Association between dietary factors and plasma adiponectin concentrations in men.
|
Am J Clin Nutr
|
2005
|
1.36
|
99
|
Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk.
|
Circulation
|
2008
|
1.34
|
100
|
Multiple biomarkers and the risk of incident hypertension.
|
Hypertension
|
2007
|
1.34
|
101
|
Leisure-time physical activity and reduced plasma levels of obesity-related inflammatory markers.
|
Obes Res
|
2003
|
1.34
|
102
|
Inflammation and changes in metabolic syndrome abnormalities in US adolescents: findings from the 1988-1994 and 1999-2000 National Health and Nutrition Examination Surveys.
|
Clin Chem
|
2006
|
1.34
|
103
|
C-reactive protein and incident cardiovascular events among men with diabetes.
|
Diabetes Care
|
2004
|
1.33
|
104
|
Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes.
|
J Clin Oncol
|
2012
|
1.32
|
105
|
Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: an analysis of the PROVE-IT TIMI-22 trial.
|
J Am Coll Cardiol
|
2005
|
1.31
|
106
|
Moderate alcohol consumption and lower levels of inflammatory markers in US men and women.
|
Atherosclerosis
|
2005
|
1.30
|
107
|
Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessment.
|
Clin Chem
|
2003
|
1.29
|
108
|
C-peptide, insulin-like growth factor binding protein-1, glycosylated hemoglobin, and the risk of distal colorectal adenoma in women.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
1.27
|
109
|
Effects of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes: the LANCET randomized trial.
|
JAMA
|
2009
|
1.27
|
110
|
Hormonal profile of diabetic men and the potential link to prostate cancer.
|
Cancer Causes Control
|
2008
|
1.26
|
111
|
Inflammation and progressive nephropathy in type 1 diabetes in the diabetes control and complications trial.
|
Diabetes Care
|
2008
|
1.25
|
112
|
Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index.
|
Am J Cardiol
|
2003
|
1.25
|
113
|
Longitudinal association of glycemia and microalbuminuria: the Framingham Offspring Study.
|
Diabetes Care
|
2002
|
1.25
|
114
|
Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes.
|
Diabetes Care
|
2004
|
1.24
|
115
|
Body iron stores and their determinants in healthy postmenopausal US women.
|
Am J Clin Nutr
|
2003
|
1.22
|
116
|
D-dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease.
|
Circulation
|
2003
|
1.22
|
117
|
Sex steroid hormone concentrations and risk of death in US men.
|
Am J Epidemiol
|
2010
|
1.22
|
118
|
Effects of GH in women with abdominal adiposity: a 6-month randomized, double-blind, placebo-controlled trial.
|
Eur J Endocrinol
|
2012
|
1.21
|
119
|
C-reactive protein: a nontraditional serum marker of cardiovascular risk.
|
Cardiovasc Pathol
|
2007
|
1.21
|
120
|
Body fatness and sex steroid hormone concentrations in US men: results from NHANES III.
|
Cancer Causes Control
|
2011
|
1.21
|
121
|
Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studies.
|
J Proteome Res
|
2013
|
1.20
|
122
|
Soluble intercellular adhesion molecules, soluble vascular cell adhesion molecules, and risk of coronary heart disease.
|
Obesity (Silver Spring)
|
2006
|
1.19
|
123
|
Serum sex steroid hormones and lower urinary tract symptoms in Third National Health and Nutrition Examination Survey (NHANES III).
|
Urology
|
2007
|
1.17
|
124
|
D-dimer and inflammatory markers as predictors of functional decline in men and women with and without peripheral arterial disease.
|
J Am Geriatr Soc
|
2005
|
1.16
|
125
|
Fructose, glycemic load, and quantity and quality of carbohydrate in relation to plasma C-peptide concentrations in US women.
|
Am J Clin Nutr
|
2004
|
1.15
|
126
|
Valsartan, blood pressure reduction, and C-reactive protein: primary report of the Val-MARC trial.
|
Hypertension
|
2006
|
1.15
|
127
|
Stability of measurements of biomarkers of oxidative stress in blood over 36 hours.
|
Cancer Epidemiol Biomarkers Prev
|
2004
|
1.14
|
128
|
Metabolic syndrome components and colorectal adenoma in the CLUE II cohort.
|
Cancer Causes Control
|
2009
|
1.13
|
129
|
Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial.
|
J Am Coll Cardiol
|
2005
|
1.13
|
130
|
Plasma folate, vitamin B6, vitamin B12, and homocysteine and pancreatic cancer risk in four large cohorts.
|
Cancer Res
|
2007
|
1.13
|
131
|
Inflammatory biomarkers, death, and recurrent nonfatal coronary events after an acute coronary syndrome in the MIRACL study.
|
J Am Heart Assoc
|
2013
|
1.11
|
132
|
Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in women.
|
Atherosclerosis
|
2011
|
1.11
|
133
|
Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
|
J Am Coll Cardiol
|
2009
|
1.11
|
134
|
Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 Trial.
|
Eur Heart J
|
2010
|
1.10
|
135
|
High-sensitivity C-reactive protein, other markers of inflammation, and the incidence of macular degeneration in women.
|
Arch Ophthalmol
|
2007
|
1.10
|
136
|
Elevated levels of inflammation, d-dimer, and homocysteine are associated with adverse calf muscle characteristics and reduced calf strength in peripheral arterial disease.
|
J Am Coll Cardiol
|
2007
|
1.09
|
137
|
Alcohol consumption patterns and HbA1c, C-peptide and insulin concentrations in men.
|
J Am Coll Nutr
|
2003
|
1.08
|
138
|
Regular consumption of nuts is associated with a lower risk of cardiovascular disease in women with type 2 diabetes.
|
J Nutr
|
2009
|
1.08
|
139
|
Cardiac troponin increases among runners in the Boston Marathon.
|
Ann Emerg Med
|
2006
|
1.08
|
140
|
Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events.
|
Circulation
|
2006
|
1.07
|
141
|
Plasma fluorescent oxidation products: independent predictors of coronary heart disease in men.
|
Am J Epidemiol
|
2007
|
1.06
|
142
|
Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes.
|
Atherosclerosis
|
2006
|
1.05
|
143
|
HFE genetic variability, body iron stores, and the risk of type 2 diabetes in U.S. women.
|
Diabetes
|
2005
|
1.05
|
144
|
Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study.
|
Circulation
|
2004
|
1.04
|
145
|
Impact of vitamin D supplementation on inflammatory markers in African Americans: results of a four-arm, randomized, placebo-controlled trial.
|
Cancer Prev Res (Phila)
|
2013
|
1.04
|
146
|
C-reactive protein and colorectal adenoma in the CLUE II cohort.
|
Cancer Causes Control
|
2008
|
1.03
|
147
|
Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels and the risk of prostate cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
1.02
|
148
|
Racial variation in sex steroid hormones and the insulin-like growth factor axis in umbilical cord blood of male neonates.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.02
|
149
|
Circulating levels of resistin and risk of type 2 diabetes in men and women: results from two prospective cohorts.
|
Diabetes Care
|
2008
|
1.01
|
150
|
Interleukin-6 receptor gene, plasma C-reactive protein, and diabetes risk in women.
|
Diabetes
|
2008
|
1.01
|
151
|
Hemochromatosis gene mutations, body iron stores, dietary iron, and risk of colorectal adenoma in women.
|
J Natl Cancer Inst
|
2005
|
1.01
|
152
|
Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium.
|
Blood
|
2012
|
1.01
|
153
|
Long-term effect of combined vitamins E and C on coronary and peripheral endothelial function.
|
J Am Coll Cardiol
|
2004
|
1.01
|
154
|
Relationship of sex steroid hormones with bone mineral density (BMD) in a nationally representative sample of men.
|
Clin Endocrinol (Oxf)
|
2008
|
1.00
|
155
|
Clinical and genetic correlates of serum aldosterone in the community: the Framingham Heart Study.
|
Am J Hypertens
|
2005
|
1.00
|
156
|
Adipocytokines, inflammation, and breast cancer risk in postmenopausal women: a prospective study.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.99
|
157
|
Reporting bias in diagnostic and prognostic studies: time for action.
|
Clin Chem
|
2008
|
0.99
|
158
|
Intra-individual variation in serum C-reactive protein over 4 years: an implication for epidemiologic studies.
|
Cancer Causes Control
|
2010
|
0.99
|
159
|
Excessive body iron stores are not associated with risk of coronary heart disease in women.
|
J Nutr
|
2008
|
0.98
|
160
|
Clinical application of C-reactive protein across the spectrum of acute coronary syndromes.
|
Clin Chem
|
2007
|
0.97
|
161
|
Inflammation, statin therapy, and risk of stroke after an acute coronary syndrome in the MIRACL study.
|
Arterioscler Thromb Vasc Biol
|
2007
|
0.97
|
162
|
Long-term prognostic value of neopterin: a novel marker of monocyte activation in patients with acute coronary syndrome.
|
Circulation
|
2007
|
0.97
|
163
|
A cross-sectional study of alcohol consumption patterns and biologic markers of glycemic control among 459 women.
|
Diabetes Care
|
2003
|
0.96
|
164
|
No association between pre-diagnostic plasma C-reactive protein concentration and subsequent prostate cancer.
|
Prostate
|
2004
|
0.96
|
165
|
A comparison of the short-term effects of oral conjugated equine estrogens versus transdermal estradiol on C-reactive protein, other serum markers of inflammation, and other hepatic proteins in naturally menopausal women.
|
J Clin Endocrinol Metab
|
2008
|
0.95
|
166
|
Functional decline in patients with and without peripheral arterial disease: predictive value of annual changes in levels of C-reactive protein and D-dimer.
|
J Gerontol A Biol Sci Med Sci
|
2006
|
0.95
|
167
|
Relation between soluble intercellular adhesion molecule-1, statin therapy, and long-term risk of clinical cardiovascular events in patients with previous acute coronary syndrome (from PROVE IT-TIMI 22).
|
Am J Cardiol
|
2006
|
0.94
|
168
|
Biomarker discovery and validation.
|
Clin Chem
|
2006
|
0.94
|
169
|
Circulating blood markers and functional impairment in peripheral arterial disease.
|
J Am Geriatr Soc
|
2008
|
0.94
|
170
|
What is a biomarker? Research investments and lack of clinical integration necessitate a review of biomarker terminology and validation schema.
|
Scand J Clin Lab Invest Suppl
|
2010
|
0.93
|
171
|
The prevalence of low sex steroid hormone concentrations in men in the Third National Health and Nutrition Examination Survey (NHANES III).
|
Clin Endocrinol (Oxf)
|
2011
|
0.93
|
172
|
Interleukin-6 receptor gene variations, plasma interleukin-6 levels, and type 2 diabetes in U.S. Women.
|
Diabetes
|
2007
|
0.93
|
173
|
Lipoprotein (a) and coronary heart disease among women: beyond a cholesterol carrier?
|
Eur Heart J
|
2005
|
0.93
|
174
|
Plasma concentration of heat shock protein 27 and risk of cardiovascular disease: a prospective, nested case-control study.
|
Clin Chem
|
2007
|
0.92
|
175
|
Endogenous sex steroid hormones and measures of chronic kidney disease (CKD) in a nationally representative sample of men.
|
Clin Endocrinol (Oxf)
|
2008
|
0.92
|
176
|
Frequency of elevations in markers of cardiomyocyte damage in otherwise healthy newborns.
|
Am J Cardiol
|
2008
|
0.91
|
177
|
Standardization of immunoassays for measurement of high-sensitivity C-reactive protein. Phase I: evaluation of secondary reference materials.
|
Clin Chem
|
2003
|
0.91
|
178
|
Expanding options for scientific publication: is more always better?
|
Circulation
|
2013
|
0.90
|
179
|
Circulating adipocytokines and chronic kidney disease.
|
PLoS One
|
2013
|
0.89
|
180
|
A prospective study of hemoglobin A1c concentrations and risk of breast cancer in women.
|
Cancer Res
|
2006
|
0.89
|
181
|
Mediating effects of inflammatory biomarkers on insulin resistance associated with obesity.
|
Obes Res
|
2005
|
0.88
|
182
|
Plasma adrenal androgens and risk of breast cancer in premenopausal women.
|
Cancer Epidemiol Biomarkers Prev
|
2004
|
0.88
|
183
|
C-reactive protein and cardiovascular risk in the Framingham Study.
|
Arch Intern Med
|
2006
|
0.88
|
184
|
Interleukin-18 and the risk of future cardiovascular disease among initially healthy women.
|
Atherosclerosis
|
2008
|
0.87
|
185
|
Serum cardiac troponin and subclinical cardiac status in pediatric chronic renal failure.
|
Pediatrics
|
2003
|
0.87
|
186
|
Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: observations from the Pravastatin Or atorVastatin Evaluation and Infection Trial-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22).
|
Am Heart J
|
2011
|
0.87
|
187
|
Intercellular adhesion molecule 1 (ICAM1) Lys56Met and Gly241Arg gene variants, plasma-soluble ICAM1 concentrations, and risk of incident cardiovascular events in 23,014 initially healthy white women.
|
Stroke
|
2007
|
0.86
|
188
|
How to use C-reactive protein in acute coronary care.
|
Eur Heart J
|
2013
|
0.86
|
189
|
Inflammatory plasma markers and pancreatic cancer risk: a prospective study of five U.S. cohorts.
|
Cancer Epidemiol Biomarkers Prev
|
2013
|
0.86
|
190
|
Synergistic relationship between hyperglycaemia and inflammation with respect to clinical outcomes in non-ST-elevation acute coronary syndromes: analyses from OPUS-TIMI 16 and TACTICS-TIMI 18.
|
Eur Heart J
|
2007
|
0.86
|
191
|
Comparison of effect of intensive lipid lowering with atorvastatin to less intensive lowering with lovastatin on C-reactive protein in patients with stable angina pectoris and inducible myocardial ischemia.
|
Am J Cardiol
|
2002
|
0.86
|
192
|
Evaluation of the AccuTnI cardiac troponin I assay for risk assessment in acute coronary syndromes.
|
Clin Chem
|
2003
|
0.85
|
193
|
Rapid and simple tandem mass spectrometry method for determination of serum cotinine concentration.
|
Clin Chem
|
2004
|
0.85
|
194
|
Plasma dehydroepiandrosterone and risk of myocardial infarction in women.
|
Clin Chem
|
2008
|
0.84
|
195
|
Comparative analysis of zinc protoporphyrin and blood lead levels in lead-exposed Andean children.
|
Clin Biochem
|
2007
|
0.84
|
196
|
Effect of pravastatin on LDL particle concentration as determined by NMR spectroscopy: a substudy of a randomized placebo controlled trial.
|
Eur Heart J
|
2003
|
0.84
|
197
|
Association of C-reactive protein and serum amyloid A with recurrent coronary events in stable patients after healing of acute myocardial infarction.
|
Am J Cardiol
|
2002
|
0.84
|
198
|
Racial variation in umbilical cord blood leptin concentration in male babies.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
0.84
|
199
|
Prospective evaluation of B-type natriuretic peptide concentrations and the risk of type 2 diabetes in women.
|
Clin Chem
|
2013
|
0.84
|
200
|
Impact of the third cholesterol report from the adult treatment panel of the national cholesterol education program on the clinical laboratory.
|
Clin Chem
|
2002
|
0.84
|
201
|
Association between C-peptide concentration and prostate cancer incidence in the CLUE II cohort study.
|
Cancer Prev Res (Phila)
|
2010
|
0.84
|
202
|
Cross-sectional relations of urinary sodium excretion to cardiac structure and hypertrophy. The Framingham Heart Study.
|
Am J Hypertens
|
2004
|
0.83
|
203
|
Serum sex steroid hormones and frailty in older American men of the Third National Health and Nutrition Examination Survey (NHANES III).
|
Aging Male
|
2012
|
0.83
|
204
|
Frequency of clinically unsuspected myocardial injury at a children's hospital.
|
Am Heart J
|
2006
|
0.83
|
205
|
Elevated plasma levels of endostatin are associated with chronic kidney disease.
|
Am J Nephrol
|
2012
|
0.83
|
206
|
Common variants of the endothelial nitric oxide synthase gene and the risk of coronary heart disease among U.S. diabetic men.
|
Diabetes
|
2006
|
0.82
|
207
|
Circulating inflammatory and endothelial markers and risk of hypertension in white and black postmenopausal women.
|
Clin Chem
|
2011
|
0.82
|
208
|
Racial variation in vitamin D cord blood concentration in white and black male neonates.
|
Cancer Causes Control
|
2012
|
0.82
|
209
|
Commercial immunoassays in biomarkers studies: researchers beware!
|
Clin Chem
|
2012
|
0.82
|
210
|
Relationship of antihypertensive treatment to plasma markers of vascular inflammation and remodeling in the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis study.
|
Am Heart J
|
2012
|
0.82
|
211
|
Mechanisms and biomarkers of cardiovascular injury induced by phosphodiesterase inhibitor III SK&F 95654 in the spontaneously hypertensive rat.
|
Toxicol Pathol
|
2006
|
0.82
|
212
|
Racial variation in umbilical cord blood sex steroid hormones and the insulin-like growth factor axis in African-American and white female neonates.
|
Cancer Causes Control
|
2012
|
0.81
|
213
|
The association of urinary cadmium with sex steroid hormone concentrations in a general population sample of US adult men.
|
BMC Public Health
|
2008
|
0.81
|
214
|
The prognostic value of serum myoglobin in patients with non-ST-segment elevation acute coronary syndromes. Results from the TIMI 11B and TACTICS-TIMI 18 studies.
|
J Am Coll Cardiol
|
2002
|
0.81
|
215
|
Relationship of sex steroid hormones with body size and with body composition measured by dual-energy X-ray absorptiometry in US men.
|
Cancer Causes Control
|
2012
|
0.80
|
216
|
Elevated concentration of placental growth factor (PlGF) and long term risk in patients with acute coronary syndrome in the PROVE IT-TIMI 22 trial.
|
J Thromb Thrombolysis
|
2012
|
0.80
|
217
|
An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports.
|
Clin Chem Lab Med
|
2012
|
0.80
|
218
|
Nonfasting low-density lipoprotein testing: utility for cholesterol screening in pediatric primary care.
|
Clin Pediatr (Phila)
|
2007
|
0.80
|
219
|
Inhibition of the renin-angiotensin system reduces the rise in serum aldosterone in acute coronary syndrome patients with preserved left ventricular function: observations from the AVANT GARDE-TIMI 43 trial.
|
Clin Chem
|
2013
|
0.79
|
220
|
A multiplex immunoassay gives different results than singleplex immunoassays which may bias epidemiologic associations.
|
Clin Biochem
|
2012
|
0.79
|
221
|
Plasma adiponectin and the risk of hypertension in white and black postmenopausal women.
|
Clin Chem
|
2012
|
0.79
|
222
|
High-sensitivity C-reactive protein and cardiovascular disease.
|
Clin Chem
|
2008
|
0.79
|
223
|
Alcohol consumption and high-density lipoprotein levels: the effect of ADH1C genotype, gender and menopausal status.
|
Atherosclerosis
|
2005
|
0.79
|
224
|
Serum cardiac troponin T as a biomarker for acute myocardial injury induced by low doses of isoproterenol in rats.
|
Cardiovasc Toxicol
|
2006
|
0.79
|
225
|
Association between sex steroid hormones and hematocrit in a nationally representative sample of men.
|
J Androl
|
2012
|
0.78
|
226
|
A message from the laboratory community to the National Cholesterol Education Program Adult Treatment Panel IV.
|
Clin Chem
|
2012
|
0.78
|
227
|
The riddle of protein diagnostics: future bleak or bright?
|
Clin Chem
|
2012
|
0.78
|
228
|
Endogenous tissue plasminogen activator and risk of recurrent cardiac events after an acute coronary syndrome in the MIRACL study.
|
Atherosclerosis
|
2009
|
0.78
|
229
|
Lack of association between soluble CD40L and risk in a large cohort of patients with acute coronary syndrome in OPUS TIMI-16.
|
J Thromb Thrombolysis
|
2007
|
0.78
|
230
|
Association between inflammatory markers, hemostatic, and lipid factors in postinfarction patients.
|
Am J Cardiol
|
2003
|
0.78
|
231
|
Early dynamic risk stratification with baseline troponin levels and 90-minute ST-segment resolution to predict 30-day cardiovascular mortality in ST-segment elevation myocardial infarction: analysis from CLopidogrel as Adjunctive ReperfusIon TherapY (CLARITY)-Thrombolysis in Myocardial Infarction (TIMI) 28.
|
Am Heart J
|
2010
|
0.78
|
232
|
High sensitivity C-reactive protein: an emerging role in cardiovascular risk assessment.
|
Crit Rev Clin Lab Sci
|
2002
|
0.78
|
233
|
Association of serum cholesterol and cholesterol-lowering drug use with serum sex steroid hormones in men in NHANES III.
|
Cancer Causes Control
|
2010
|
0.77
|
234
|
Frequent intake of tropical fruits that are rich in beta-cryptoxanthin is associated with higher plasma beta-cryptoxanthin concentrations in Costa Rican adolescents.
|
J Nutr
|
2002
|
0.77
|
235
|
Association between endogenous sex steroid hormones and insulin-like growth factor proteins in US men.
|
Cancer Causes Control
|
2014
|
0.77
|
236
|
Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial).
|
Am J Cardiol
|
2006
|
0.77
|
237
|
No effect of beta-carotene supplementation on risk of nonmelanoma skin cancer among men with low baseline plasma beta-carotene.
|
Cancer Epidemiol Biomarkers Prev
|
2004
|
0.76
|
238
|
Declining blood lead and zinc protoporphyrin levels in Ecuadorian Andean children.
|
Clin Biochem
|
2013
|
0.76
|
239
|
Publication ethics: clinical chemistry editorial standards.
|
Clin Chem
|
2008
|
0.76
|
240
|
Association of resistin promoter polymorphisms with plasma resistin levels and type 2 diabetes in women and men.
|
Int J Mol Epidemiol Genet
|
2010
|
0.76
|
241
|
Statistical methods for test and biomarker evaluation studies: a clinical chemistry series.
|
Clin Chem
|
2012
|
0.76
|
242
|
An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports.
|
Scand J Clin Lab Invest
|
2012
|
0.75
|
243
|
Evaluation of an enzymatic homocysteine assay for the Hitachi series chemistry analyzer.
|
Clin Chim Acta
|
2005
|
0.75
|
244
|
Full disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors.
|
Ann Clin Biochem
|
2011
|
0.75
|
245
|
An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports.
|
Clin Chem
|
2012
|
0.75
|
246
|
Full-disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors.
|
Clin Chem Lab Med
|
2010
|
0.75
|
247
|
Full-disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors.
|
Scand J Clin Lab Invest
|
2010
|
0.75
|
248
|
An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports.
|
Am J Hematol
|
2012
|
0.75
|
249
|
Full-disclosure in industry-sponsored laboratory medicine research studies: Statement by the Consortium of Laboratory Medicine Journal Editors.
|
Am J Hematol
|
2011
|
0.75
|
250
|
Full-disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors.
|
Clin Chim Acta
|
2010
|
0.75
|
251
|
Measurement of whole blood sirolimus by an HPLC assay using solid-phase extraction and UV detection.
|
Ther Drug Monit
|
2002
|
0.75
|
252
|
An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports.
|
Clin Biochem
|
2012
|
0.75
|
253
|
International Year of Chemistry 2011: Clinical Chemistry celebrates.
|
Clin Chem
|
2010
|
0.75
|
254
|
Full disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors.
|
Transfusion
|
2010
|
0.75
|
255
|
Colloquium on rethinking the future of scientific communication.
|
Clin Chem
|
2012
|
0.75
|
256
|
Normal homocysteine levels in a population of children with inflammatory bowel disease.
|
Inflamm Bowel Dis
|
2005
|
0.75
|
257
|
Full disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors.
|
Clin Chem
|
2010
|
0.75
|
258
|
Preparation of manuscripts for publication: improving your chances for success.
|
Clin Chem
|
2009
|
0.75
|
259
|
Standardization of high-sensitivity immunoassays for measurement of C-reactive protein; II: Two approaches for assessing commutability of a reference material.
|
Clin Chem
|
2008
|
0.75
|